Open Journal of Rheumatology and Autoimmune Diseases

Volume 10, Issue 2 (May 2020)

ISSN Print: 2163-9914   ISSN Online: 2164-005X

Google-based Impact Factor: 0.26  Citations  

Anaphylactic Reaction to a Change in the Route of Administration of Abatacept: A Case Study

HTML  XML Download Download as PDF (Size: 224KB)  PP. 64-69  
DOI: 10.4236/ojra.2020.102008    496 Downloads   988 Views  
Author(s)

ABSTRACT

The incidence of anaphylactic reaction after the long-term use of abatacept has not been reported until now. Herein, we present a case of rheumatoid arthritis (RA) in which the patient experienced an anaphylactic reaction one year after initiation of treatment with abatacept. A 75-year-old woman visited our hospital with symptoms of bilateral knee pain and swelling. She was initially treated with methotrexate (6 mg/week increased to 8 mg/week). Two months later, because of inadequate response, self-injections of abatacept (subcutaneous; 125 mg every two weeks) were prescribed. However, 6 months later, because of frequent stomatitis, the methotrexate dose was decreased to 6 mg/week, which resulted in worsening of RA. We changed the route of abatacept administration from subcutaneous injection to intravenous infusion (500 mg/month as a drip). After 30 min of starting the drip, the patient experienced itchiness and drop in vital signs, which were managed using methylprednisolone (2 doses, 125 mg each), dopamine hydrochloride (8 mg/h), and oxygen therapy (flow decreased from 3 L/min to 1 L/min). Wheals and redness were treated with oral antihistamines. Six hours after the onset of the anaphylactic reaction, the vital signs were stabilized. On the subsequent day, the patient’s general state was confirmed to be normal. One month later, etanercept (25 mg) treatment was initiated. The patient is currently in remission. We recommend caution when changing the route of administration and dosage of abatacept in anti-cyclic citrullinated peptide antibody-positive patients or those with a history of mild infusion-related reaction.

Share and Cite:

Imai, K. , Tokunaga, D. and Ishida, M. (2020) Anaphylactic Reaction to a Change in the Route of Administration of Abatacept: A Case Study. Open Journal of Rheumatology and Autoimmune Diseases, 10, 64-69. doi: 10.4236/ojra.2020.102008.

Cited by

No relevant information.

Sponsors, Associates, and Links
  翻译:
Follow SCIRP
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat

Copyright © 2025 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.

  翻译: